Peter Boumenot - 07 Mar 2022 Form 4 Insider Report for Signify Health, Inc.

Role: Chief Product Officer
Signature: /s/ Adam McAnaney as Attorney-in-Fact for Peter Boumenot
Issuer symbol: N/A
Transactions as of: 07 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2022, 17:05:51 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGFY	Class A Common Stock	Award	$0	+35,237		$0.000000	35,237	07 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SGFY	Employee Stock Option (Right to Buy)	Award	$0	+105,711		$0.000000	105,711	07 Mar 2022	Class A Common Stock	105,711	$14.19	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units on March 7, 2022 that will vest in equal annual installments on each of the first four anniversaries of the grant date.
F2	These options vest in equal annual installments on each of the first four anniversaries of the March 7, 2022 grant date.